India’s Sun Pharmaceutical Gets FDA Warning – Wall Street Journal


Wall Street Journal
India’s Sun Pharmaceutical Gets FDA Warning
Wall Street Journal
This is the latest setback for India’s pharmaceutical companies, which have struggled with quality issues under the increased scrutiny from the FDA. Indian companies account for around 40% of generic drug sales in the U.S.. U.S. inspectors in September
Sun Pharmaceutical Industries US FDA warns India’s Sun Pharma over standards Nikkei Asian Review

all 77 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd